← Coach — Cardiology · Coach hub

Coach — Pulmonary: The Oxidizer Organ

The lung is not a passive exchanger. It delivers the other half of the fire: the oxygen that lets every cell finish burning what the gut supplies.

We tend to picture breathing as plumbing. Air in, air out, a bellows that either works or does not. When it falters we give the failure a name, asthma, COPD, sleep apnea, fibrosis, and aim a remedy at the name. This hypothesis starts somewhere else. It proposes that we are born with perfect biology, perfect for intermittent food, natural light and dark, and the movement and strength that defined human life. What we call chronic disease is, in most cases, that same biology running in compensatory mode because its capacity to make energy has been worn down by mismatch. Acute compensation is life-saving. Chronic compensation becomes the pathology we name and attempt to suppress.

Two deliveries, one fire

Inside cells, the mitochondria pass electrons down a chain to a final acceptor, and that acceptor is oxygen. The gut delivers the fuel. The lungs deliver the oxygen that completes the circuit. The heart and vessels then carry the fuel-laden, oxygenated blood to every tissue. In this picture the lung is the specialized organ of oxidizer delivery, and its health cannot be separated from what and when we eat, from the heart's output and the resilience of its right side, from the body's handling of iron, or from the microbes that educate both the gut lining and the airway lining.

Seen that way, the named lung diseases are local versions of one upstream problem: too little oxidative energy for the load. A tissue short of that energy has a few fallbacks. It can lean on sugar-burning glycolysis, call in inflammation, remodel its own structure, or, at the far end, become the ground in which cancerous cells are selected.

A lung that senses

The lung carries its own version of the enzyme at the end of the energy chain, cytochrome c oxidase, built with a lung-enriched part called COX4i2. Lung enzyme of this kind shows roughly twofold higher activity than the common form. It sits in the muscle of the small lung arteries and is required for a quiet, clever reflex: when one patch of lung is poorly ventilated, its vessels tighten and send blood toward better-aired regions. Without COX4i2, that reflex is gone. Knocking it out also makes airways less reactive to a provoking challenge, yet the lung slowly develops disease. The same enzyme both senses local oxygen and supplies the energy that airway muscle and costly tissue upkeep demand.

Iron and serotonin tune this circuit. Iron sits in hemoglobin, the blood's oxygen carrier, and it can also drive damaging oxidative chemistry. Cigarette smoke brings iron in from outside and scrambles how cells take it up, so the lungs of smokers accumulate iron and ferritin. Functional iron deficiency has been linked to several asthma patterns, while iron overload inside cells drives mucus and scarring. Serotonin, made by specialized nerve-like cells in the lung and pulled into vessel walls by its transporter, shifts vascular tone, airway reactivity, and remodeling. More of that transporter tracks with pulmonary hypertension in COPD.

The gut joins the conversation. Gut-made serotonin, short-chain fatty acids, and tryptophan products shape the lung's immune cells and their set-points, and lung inflammation and low oxygen in turn alter the gut barrier and its microbes. Fuel delivery and oxygen delivery are not separate departments.

One shortfall, many names

Across chronic lung disease, the shared thread is mitochondrial trouble: sluggish flow through the energy chain, excess reactive oxygen, disordered fission and fusion, and poor clearance of worn-out mitochondria. It shows up in lining cells, airway muscle, vessel walls, and resident immune cells. These are not independent lesions. They are the local sign of too little energy headroom. Metabolic syndrome, circadian disruption, and the absence of hormetic stress lower the threshold at which an inhaled insult or bouts of low oxygen lock those compensations into place.

Asthma is usually told as allergic inflammation. Through the metabolic lens it is an airway wall short of energy. Airway muscle from people with asthma carries more mitochondria and consumes more oxygen, driven by altered calcium handling, and that supports muscle that grows and squeezes too readily. Constriction itself is expensive. Lining cells with failing mitochondria let the barrier break down and amplify inflammation. Iron maps onto the same story, and obesity and metabolic syndrome add a body-wide energy deficit the airway cannot resolve without chronic remodeling.

COPD, in this reading, is accelerated compensatory aging of the oxidizer organ. Smoke delivers iron, raises mitochondrial reactive oxygen, impairs mitochondrial clean-up, and pushes cells toward senescence. The activity of the end-of-chain enzyme declines in step with airflow limitation. Emphysema is what remains when the costly upkeep of the air sacs, surfactant, barrier integrity, debris clearance, can no longer be sustained. Metabolic syndrome is present in up to half of patients, which fits a shared upstream shortfall.

Sleep apnea delivers oxygen in broken pulses. Each cycle of low oxygen and reoxygenation impairs the energy chain, much like repeated ischemia and reperfusion, and the bill arrives as endothelial dysfunction, insulin resistance, sympathetic activation, and illness across many organs. The collapsing upper airway can be read, in part, as an energy-dependent failure of the muscles that keep it open. The contrast is the lesson. Controlled intermittent hypoxic training can build mitochondria through hormesis; the uncontrolled intermittent hypoxia of sleep apnea does the reverse. Broken sleep also disrupts the night's window of mitochondrial clean-up and redox restoration, while the strain on the right heart couples the problem directly to cardiac energy.

Lung cancer becomes bioenergetic selection in a high-oxygen niche. Cells that lose oxidative capacity, through smoking damage to mitochondrial DNA, iron-driven reactive oxygen, chronic inflammation, or fuel overload, must fall back on cruder energy pathways. That state raises the mutation rate and favors clones that scavenge any carbon they can find. Many lung cancers still retain or even depend on their mitochondria and shift flexibly between pathways. The same mismatch that produces COPD and metabolic syndrome creates the soil in which these compromised cells are selected.

Infection is a contest for iron, oxygen, and energy. The lung's resident immune cells hide iron as nutritional immunity and make reactive oxygen to kill. Tuberculosis and other pathogens manipulate host iron handling and mitochondria to survive. Mitochondrial iron loading in the immune cells of smokers or people with COPD helps bacteria such as Streptococcus pneumoniae persist, and dysbiosis in the gut raises susceptibility to pneumonia and tuberculosis. Fighting infection costs a great deal of energy. When that energy is already short, the inflammatory response fails to resolve and an acute insult hardens into chronic damage. Strategies that support mitochondrial quality and iron balance, in this view, complement antimicrobial therapy.

Fibrosis reads as failed repair under mitochondrial attrition. In idiopathic pulmonary fibrosis, the surfactant-making cells lose oxidative capacity and release damage signals that activate scar-forming fibroblasts, a loop sustained by defective mitophagy, excess reactive oxygen, and a shift toward glycolysis. Acute respiratory distress syndrome, critical illness, and post-viral syndromes, including aspects of long COVID, are extreme expressions of the same failure. Sarcoidosis, vasculitis, and related immune lung disease follow the logic of the immune system at large: resolution is energy-expensive, and it fails first.

The engine, not the dashboard

The response this hypothesis points to runs through the same three pillars that apply everywhere else in the body.

Fuel means substrates mitochondria oxidize cleanly and less chronic fermentable load. Ketone bodies offer an alternative fuel, and fermented fibers feed the gut microbes that speak to the lung. Proper fuel reduces insulin resistance, a shared driver of COPD, fibrosis risk, and the cancer microenvironment, and it lowers the right heart's energy demand.

Circadian alignment means natural light and dark and intact sleep, which protect the nightly recovery window that intermittent hypoxia and modern lighting destroy. The body’s own nightly melatonin supports mitochondrial antioxidant capacity.

Strength means hormesis that expands mitochondrial density and quality throughout the body and, when applied to the breathing and throat muscles, locally. Progressive resistance raises the energy headroom of airway muscle, the diaphragm, and the dilator muscles, and improves the resilience of the right heart. Layered mitochondrial supports can help where indicated, but they remain secondary.

Asthma, COPD, sleep-disordered breathing, lung cancer, infection, fibrosis, and immune-inflammatory disease are not independent entities in this view. They are chronic compensations of an airway and lung circulation whose energy capacity, iron-redox balance, serotonin-tuned sensing, and conversation with the gut have been eroded by mismatch. Restoring ancestral fuel, circadian alignment, and strength raises the probability that acute compensations remain reversible and that chronic lock-in is attenuated. The engine, not the dashboard, remains the proper target.

Individual circumstances vary; any interventions should be undertaken only under appropriate medical supervision.

A working hypothesis, open to correction and revised as new evidence arrives. Last revised October 17, 2026.

Related: Cardiology (cardiopulmonary chapter) · Pulmonary (extended report) · Immune · Fuel · Circadian · Strength

See the notice at the top of this page. Working hypothesis, not medical advice.